FSD Pharma seeks FDA nod for FSD201 phase 2 trial in Covid-19 patients

This article was originally published here

In this connection, the Canadian pharma company has submitted an investigational new drug (IND) application for FSD201 with the US regulator. The phase 2 trial will be a

The post FSD Pharma seeks FDA nod for FSD201 phase 2 trial in Covid-19 patients appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply